Glaxo: A History to 1962Glaxo is the world's second largest pharmaceutical multinational. This study of the company, from its beginnings to 1962, is based on unprecedented and unparalleled archival access to the company records. It gives a detailed account of the global operations of Glaxo, and describes not only the evolution of this international business, but studies its research and development programmes, its products, and its marketing and management. It is a story of power, money and drugs, the first comprehensive study of a UK-based drugs company and the only scholarly study yet written of a front-ranking world company. |
Contents
The origins Joseph Nathan Co | 5 |
The Nathans and proprietary foods 19031918 | 17 |
Boom and depression for Glaxo and the Nathans | 46 |
Glaxo Laboratories Ltd | 68 |
Early internationalisation and the growth of overseas | 98 |
the Second | 135 |
Pharmaceuticals triumphant 19461962 | 155 |
a strategy of science? | 175 |
North and South America | 242 |
India and Pakistan | 273 |
Australia and New Zealand | 298 |
South Africa | 315 |
Glaxo in Europe | 338 |
Epilogue | 362 |
Notes | 377 |
397 | |
The development and commercial exploitation | 200 |
Glaxo Laboratories and the international development | 225 |
Common terms and phrases
advertising agreement Alec Nathan Allen & Hanburys American antibiotics Argentina Australia baby Barnard Castle Birchley Board Britain British Canada Canadian cent chemical chemists commercial Committee company's competition competitors cortisone cost dried milk drugs early Ergosterol established Evans Medical export factory Farex fermentation Fred Nathan Gent Glaxo Archives Glaxo Baby Glaxo department Glaxo powder Glaxo products Glaxo's research Greenford griseofulvin Harvalias Ibid important increased India investment Italy Jephcott Jephcott to Palmer Johnson & Johnson Joseph Nathan licences managing director manufacture Merck milk powder Ministry multinational Nathan & Co operations organisation Ostelin overseas subsidiaries Pacey packing Pakistan parent company patent penicillin pharmaceutical companies pharmaceutical industry plant Port Fairy post-war problems profit programme proprietary reported representatives research and development result Schering shares South Africa Squibb staff streptomycin supplies Tizard trade turnover vaccine vitamin B₁₂ vitamin D Wadeville Wilkins Zealand